Pfizer Inc. logo

Pfizer Inc. (PFE)

Market Closed
26 Jun, 20:00
NYSE NYSE
$
24. 29
+0.62
+2.6193%
$
138.41B Market Cap
14.55 P/E Ratio
0.68% Div Yield
59.91M Volume
1.43 Eps
$ 23.67
Previous Close
Add Transaction
Day Range
23.74 24.35
Year Range
23.11 28.75
Want to track PFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs

Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs

PFE's digital pharmacy aims to provide patients easy access to its medicines for COVID-19, migraine and other conditions.

Zacks | 1 year ago
Why Walgreens Boots Alliance Plunged Today

Why Walgreens Boots Alliance Plunged Today

Major drugmakers Pfizer and Eli Lilly made major direct-to-consumer announcements. While Walgreens was named as a partner for Pfizer's new direct health platform, it stands to potentially lose out on retail drug sales.

Fool | 1 year ago
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines

Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines

A brand new round of Covid shots from Pfizer and Moderna is about to reach Americans. Meanwhile, CNBC tested out Dexcom's new CGM Stelo.

Cnbc | 1 year ago
Pfizer launches new website for migraine, respiratory offerings

Pfizer launches new website for migraine, respiratory offerings

Pfizer Inc is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses.

Reuters | 1 year ago
Pfizer follows Eli Lilly's lead in direct-to-consumer push

Pfizer follows Eli Lilly's lead in direct-to-consumer push

Pfizer Inc. on Tuesday unveiled a new online platform designed to help simplify and coordinate healthcare for consumers, adding momentum to an emerging trend in big pharma that has drawn criticism from some provider groups and policy experts.

Marketwatch | 1 year ago
Is Pfizer Stock Still a Buy After an Unexpected Setback?

Is Pfizer Stock Still a Buy After an Unexpected Setback?

One of Pfizer's vaccine programs failed to demonstrate its utility. Its competitors had the same issue with their programs.

Fool | 1 year ago
FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs

FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs

On Thursday, the FDA cleared new versions of Pfizer's (PFE) and Moderna's (MRNA) COVID-19 vaccines that are designed to match COVID-19 strains currently circulating in the country.

Zacks | 1 year ago
3 Stocks Under $50 Smart Investors Should Buy Hand Over Fist

3 Stocks Under $50 Smart Investors Should Buy Hand Over Fist

It is never too early to start your investment journey.

247wallst | 1 year ago
New Pfizer and Moderna Covid-19 vaccines approved by US

New Pfizer and Moderna Covid-19 vaccines approved by US

US regulators have approved a new series of updated and improved COVID-19 vaccines to target a resurgence of the virus as new strains emerge. Pfizer Inc (NYSE:PFE, ETR:PFE) and Moderna Inc (NASDAQ:MRNA, ETR:0QF) are set to begin shipping immediately while a third US manufacturer, Novavax, expects to start deliveries later.

Proactiveinvestors | 1 year ago
Updated COVID-19 vaccines from Pfizer, Moderna approved by FDA

Updated COVID-19 vaccines from Pfizer, Moderna approved by FDA

The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country.

Marketwatch | 1 year ago
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

The Food and Drug Administration approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach most Americans in the coming days as the virus surges. The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating widely in the U.S. earlier this year.

Cnbc | 1 year ago
Looking for $1500 in Safe Passive Income Each Year? Invest This Much in Pfizer.

Looking for $1500 in Safe Passive Income Each Year? Invest This Much in Pfizer.

24/7 Wall St. Insights Pfizer is one of the highest-yielding S&P 500 stocks.

247wallst | 1 year ago
Loading...
Load More